阿斯利康是一家科学至上的全球性生物制药企业，专注于研发、生产及营销处方类药品。阿斯利康全球总部位于英国剑桥, 业务遍布世界130多个国家，创新药物惠及全球数百万患者。阿斯利康始终相信“科学，激发无限潜能”，秉持“不断开拓科学疆域, 研发改变生命的药物”这一使命，致力于为健康行业带去意义深远的变化。
1993年阿斯利康进入中国，专注患者亟需的治疗领域，包括肿瘤、心血管、代谢、肾脏、呼吸、消化、疫苗抗体、自体免疫、罕见病等，致力于实现”开拓创新，造福病患，成为中国最值得信赖的医疗合作伙伴”这一宏伟愿景。阿斯利康持续开展并扩大在中国生物医药领域的部署与投资，聚焦中国患者未被满足的健康需求，在药物研发、商业创新等多个领域不断推动本土创新实践。
Boehringer Ingelheim is working on breakthrough therapies that improve the lives of humans and animals. As a leading research-driven biopharmaceutical company, we create value through innovation in areas of high unmet medical need. Founded in 1885 and family-owned ever since, we take a long-term perspective. Around 52,000 employees serve more than 130 markets in Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing.
As a medium-sized consulting and planning company, we support our clients in complex industrial projects. From production, logistics, SAP and cloud solutions to architecture, operational excellence, building services and project management – with our “Lead Consulting // plus” approach, we shape the future holistically.
Our culture is characterized by team spirit, trust and the ambition to become better together.
In January 1998, 12 people with vision & courage established in Greece the subsidiary of Chiesi, an international group research-oriented in the areas of AIR/CARE/RARE. ChiesiHellas has become a forward-looking company with strong presence in the local pharmamarket for its culture and governance (2022-24Top Employer, 2024Best Workplace,2024Best Workplace4Women,2022-2024GPTW,2024 Most Sustainable Companies in GR,2021Prix Galien, BCorp since 2019).
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas – Oncology, Cardiovascular, Renal & Metabolic and Respiratory & Immunology. Our company is led with a people-first mindset and a leadership strategy that respects the importance of entrepreneurial and team-driven innovation.
We are a global, science-led, patient-focused pharmaceutical company. We are dedicated to transforming the future of healthcare by unlocking the power of what science can do for people, society and the planet.
AstraZeneca is an international innovative biopharmaceutical company. We push the boundaries of science to deliver life-changing medicines.
Die AstraZeneca GmbH mit Sitz in Hamburg ist die deutsche Tochtergesellschaft des britisch-schwedischen Pharmaunternehmens AstraZeneca PLC. AstraZeneca ist ein globales, wissenschaftsorientiertes biopharmazeutisches Unternehmen, das sich auf die Erforschung, Entwicklung und Vermarktung von verschreibungspflichtigen Medikamenten in den Bereichen Onkologie, Biopharmazeutika, seltene Erkrankungen sowie Impfstoffe & Immuntherapien konzentriert.
We are a global, science-led, patient-focused pharmaceutical company. We are dedicated to transforming the future of healthcare by unlocking the power of what science can do for people, society and the planet.
Fresenius Kabi España forma parte de Fresenius Kabi, compañía global especializada en medicamentos y tecnologías para la infusión, transfusión y nutrición clínica. Nuestra misión es clara: salvar vidas y mejorar la calidad de vida de los pacientes críticos y crónicos, ofreciendo soluciones terapéuticas de alta calidad, accesibles y seguras para los sistemas de salud.
作为首批进入中国的跨国制药企业之一，施维雅深耕中国市场的43年里，一直专注于心脏健康、高血压、糖尿病和静脉健康领域，为中国患者提供高质量药物和综合健康解决方案。随着第一款胰腺癌药物在2022年4月获批，施维雅中国也紧随集团步伐正式启动肿瘤领域的工作。秉持“成为肿瘤领域的卓越贡献者”这一愿景, 施维雅中国在难治性肿瘤方面布局了丰富的产品管线，包括结直肠癌、中枢神经系统肿瘤等，为患者带来更多样的治疗选择，改善生命质量。
Alcon is the global leader in eye care, dedicated to helping people see brilliantly. With our 70-plus-year heritage, we are the largest eye care device company in the world – with complementary businesses in Surgical and Vision Care. Being a truly global company, we work in over 60 countries and serve patients in more than 140 countries.